Purchase Order 36C24622P0024
Award Date 10/1/21
Potential Completion Date 3/31/23
Potential Value $380K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Billerica, Billerica, MA 01862, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, awarded October 1, 2024, to Progenics Pharmaceuticals Inc. (operating as a division of Lantheus Medical Imaging, Inc.) represents a $2.86M ceiling value contract for the supply of PYLARIFY injections and supporting materials to the Louisville Veterans Affairs Medical Center. The award constitutes a modification that increases the quantity of a prior delivery order by 65 percent. Issued by Veterans Integrated Service Network 9 (a component of the Department of Veterans...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9), awarded a delivery order to Pharmalogic Holdings Corp. (doing business as Pharmalogic Puerto Rico) for PYLARIFY F-18 piflufolastat radiopharmaceutical products under a five-year ordering period. This delivery order, valued at $228,549.36, represents a modification that decreased funds by $168,409.84 from a previously established ceiling. The contract utilizes a firm fixed-price structure with no set-aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a $130,952 delivery order against the Pharmaceuticals and Drugs schedule (FSS-61-IB) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., which is a subsidiary of Lantheus Holdings, Inc. The firm fixed price order is for the supply of PYLARIFY PIFLUFOLASTAT F18 injection and has a completion date of January 9, 2023. No set-aside designation was used for this...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a Blanket Purchase Agreement (BPA) call to Progenics Pharmaceuticals Inc. (a division of Lantheus Medical Imaging, Inc.) on January 1, 2026, for the supply of PYLARIFY Injection with a ceiling value of $1.25M and an ultimate completion date of December 31, 2027. This is a firm fixed-price contract with no set-aside designation issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The...
- The Department of Veterans Affairs, Veterans Integrated Service Network 7 (VISN 7) awarded a $6.16M delivery order to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., on December 15, 2022 for the supply of PYLARIFY Injections. This is a firm fixed-price contract with an ultimate completion date of December 14, 2027 and no set-aside designation. The product will be performed and delivered from the vendor's facility in North Billerica, Massachusetts. PYLARIFY...
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order to Progenics Pharmaceuticals Inc. (a division of Lantheus Medical Imaging, Inc.) for a decreased quantity of PYLARIFY Injection with a firm fixed-price contract ceiling of approximately $570K. The award, dated January 18, 2024, with an ultimate completion date of January 17, 2025, represents a modification to reduce the previously ordered quantity of this critical radiopharmaceutical. This...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23) awarded a delivery order to Progenics Pharmaceuticals Inc., operating as a division of Lantheus Medical Imaging, Inc., for the supply of PYLARIFY imaging agent on October 1, 2024. This $570,744.66 firm fixed-price delivery order, with an ultimate completion date of August 31, 2025, represents a non-competitive procurement issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VA - VHA) awarded a $281,085.60 delivery order contract to Progenics Pharmaceuticals Inc., doing business as Progenics Pharmaceuticals and a division of Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc., for PYLARIFY (PIFLUFOLASTAT F-18). PYLARIFY is a radiopharmaceutical used in positron emission tomography (PET) imaging to visualize prostate-specific membrane antigen (PSMA) in men...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $547,803.35 delivery order contract to Progenics Pharmaceuticals Inc., operating as the Lantheus Medical Imaging, Inc. Division of Lantheus Holdings, Inc., to provide EMERGENCY PYLARIFY INJECTIONS. The contract was awarded under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule and has a period of performance from October 15, 2022 through December 31, 2022....
- Progenics Pharmaceuticals Inc., operating as a division of Lantheus Medical Imaging Inc., was awarded a delivery order contract on January 2, 2026, to supply PYLARIFY (piflufolastat F-18), a diagnostic radiopharmaceutical used in positron emission tomography (PET) imaging for prostate cancer detection. The contract, issued by the Department of Veterans Affairs through Veterans Integrated Service Network 5, carries a firm fixed-price ceiling value of $9.06M with an ultimate completion date of...